Navigation Links
LSTM leads project to develop HIV/AIDS strategy for Libya
Date:8/4/2009

Liverpool School of Tropical Medicine (LSTM) is leading a project to provide technical assistance to the Libyan government to finalise the development of a national HIV strategy and programme of support. The project is supported by a 1 million grant from the Delegation of the European Commission to Libya.

Between 2009 and 2010, The International Health Group of LSTM in partnership with Libyan institutions and Harvard University's Biostatistics Department (HUBD), will produce updated and comprehensive information on the current epidemiology of HIV infection in the country in order to produce an effective national HIV strategy.

Libya is faced with the challenge of controlling HIV and the provision of appropriate treatment, care and support to children and adults with HIV and AIDS. The problem of the provision of quality care to HIV infected children is compounded by the need to control a concentrated HIV epidemic affecting mainly persons most at risk for which there is limited epidemiological data. The disease is still the object of stigma and fear and there is little known about the drivers of the epidemic among those most at risk as well as the perception of risk and knowledge of HIV among influential sectors of the community.

A skilled and diverse team will work with Libyan institutions to:

  • formulate a national HIV strategy that addresses Libya's priority issues for HIV prevention and care
  • obtain critical biological, social and behavioural estimates to guide and assess the strategy
  • analyze the data and draw evidence-based conclusions from them
  • develop policies and procedures to effectively promote best practice and evidence-based harm minimisation activities amongst key high risk groups (intravenous drug users, female sex workers, men who have sex with men), especially in prisons
  • coordinate the dissemination of key HIV strategy messages and policies

LSTM's Professor Joseph Valadez will manage the project. He is one of the pioneers of methods to rapidly assess Knowledge, Attitudes and Practices (KAP), having utilised them within HIV assessment programmes throughout the world. The KAP studies will be designed to gather knowledge and misconceptions about HIV transmission and prevention, attitudes associated with stigma and discrimination and high risk behaviours. Surveys will be based on international instruments already field tested but adapted to the Libyan context and will be used to determine how to improve training and capacity building among health facility workers, religious leaders and young people.

Commenting on the programme, Professor Valadez said: "This project will establish an overall HIV strategy for Libya and provide a framework for making important decisions about how to control HIV. It will also aid Libya to join the other countries of North Africa who have HIV strategies and participate in the international UNAIDS community. We hope this project will also allow us all to better understand how HIV is progressing in North Africa and hopefully provide us with information about how to better control it."


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpool School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Removing Ovaries Before Menopause Leads to Memory, Movement Troubles
2. Lack of sleep among new school-goers leads to behavioral, cognitive problems
3. AstraZeneca Leads Local Walking Movement
4. Leeza Gibbons Leads New Coaching Program to Boost the Nations Heart Health
5. Support System Leads to Better Diet, Nutrition
6. Brain atrophy in elderly leads to unintended racism, depression and problem gambling
7. Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder
8. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
9. In birds, expecting to mate leads to higher fertilization rates
10. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
11. Antibody leads to repair of myelin sheath in lab study of multiple sclerosis and related disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: